Viking Therapeutics, Inc. SEC filings VKTX
Viking Therapeutics, Inc. has 652 filings in SEC EDGAR's recent list, going back to May 22, 2014. Its latest annual report, Form ARS, was filed on Apr 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 28, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 305B2 | Application for designation of a new trustee | Sep 24, 2026 | — |
| DEFR14A | Filing | Apr 23, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 21, 2025 | — |
| CORRESP | Letter to the SEC | Apr 8, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 31, 2025 | — |
| EFFECT | Filing | Aug 11, 2021 | — |
| CORRESP | Letter to the SEC | Aug 5, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 2, 2021 | — |
| 25-NSE | Delisting notice | Apr 8, 2021 | — |
| CT ORDER | Filing | Feb 19, 2020 | — |
| EFFECT | Filing | Jul 19, 2018 | — |
| CORRESP | Letter to the SEC | Jul 17, 2018 | — |
| UPLOAD | Letter from the SEC | Jul 17, 2018 | — |
| EFFECT | Filing | Jan 16, 2018 | — |
| CORRESP | Letter to the SEC | Jan 11, 2018 | — |
| CORRESP | Letter to the SEC | Jan 3, 2018 | — |
| CORRESP | Letter to the SEC | Dec 29, 2017 | — |
| UPLOAD | Letter from the SEC | Dec 29, 2017 | — |
| EFFECT | Filing | Oct 26, 2017 | — |
| CORRESP | Letter to the SEC | Oct 24, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 24, 2017 | — |
| CT ORDER | Filing | Jun 27, 2017 | — |
| D | Filing | Jun 22, 2017 | — |
| EFFECT | Filing | Mar 27, 2017 | — |
| CORRESP | Letter to the SEC | Mar 22, 2017 | — |
| CT ORDER | Filing | Mar 22, 2017 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2017 | — |
| EFFECT | Filing | Sep 21, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2016 | — |
| CORRESP | Letter to the SEC | Sep 19, 2016 | — |
| EFFECT | Filing | Jul 26, 2016 | — |
| CORRESP | Letter to the SEC | Jul 22, 2016 | — |
| CT ORDER | Filing | Jul 19, 2016 | — |
| CORRESP | Letter to the SEC | Jul 15, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 14, 2016 | — |
| CERTNAS | Auto-generated paper document | Apr 8, 2016 | — |
| 8-A12B | Form 8-a12b | Apr 8, 2016 | — |
| EFFECT | Filing | Apr 7, 2016 | — |
| CORRESP | Letter to the SEC | Apr 6, 2016 | — |
| CORRESP | Letter to the SEC | Apr 6, 2016 | — |
| CORRESP | Letter to the SEC | Apr 4, 2016 | — |
| CORRESP | Letter to the SEC | Apr 1, 2016 | — |
| CORRESP | Letter to the SEC | Apr 1, 2016 | — |
| CORRESP | Letter to the SEC | Mar 31, 2016 | — |
| CORRESP | Letter to the SEC | Mar 25, 2016 | — |
| CORRESP | Letter to the SEC | Mar 8, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 9, 2015 | — |
| CT ORDER | Filing | Apr 30, 2015 | — |
| EFFECT | Filing | Apr 28, 2015 | — |
| CERTNAS | Auto-generated paper document | Apr 24, 2015 | — |
| 8-A12B | Form 8-a | Apr 23, 2015 | — |
| CORRESP | Letter to the SEC | Apr 22, 2015 | — |
| CORRESP | Letter to the SEC | Apr 22, 2015 | — |
| UPLOAD | Letter from the SEC | Mar 27, 2015 | — |
| CORRESP | Letter to the SEC | Sep 19, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2014 | — |
| CORRESP | Letter to the SEC | Sep 16, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2014 | — |
| CORRESP | Letter to the SEC | Sep 15, 2014 | — |
| CORRESP | Letter to the SEC | Sep 15, 2014 | — |
| UPLOAD | Letter from the SEC | Sep 15, 2014 | — |
| CORRESP | Letter to the SEC | Jul 1, 2014 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2014 | — |
| DRS | Filing | May 22, 2014 | — |
Showing 64 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- VKTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1607678
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.